You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Icatibant

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Icatibant in Pediatric Participants With Hereditary Angioedema

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • Icatibant
  • (no location specified)
Aug 19, 2022

SARS CoV 2 Infection Trial in Belfast (Icatibant, 0.9% Sodium Chloride Injection)

Recruiting
  • SARS CoV 2 Infection
  • Icatibant
  • 0.9% Sodium Chloride Injection
  • Belfast, Antrim, United Kingdom
    Mater Infirmorum Hospital
Jun 6, 2022

Hereditary Angioedema Who Currently Receive Icatibant at Home

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • No Intervention
  • London, United Kingdom
    Sciensus
Aug 4, 2022

Hereditary Angioedema Trial in Nagakute, Bunkyo-ku, Kagoshima (TAK-667)

Completed
Has Results
  • Hereditary Angioedema
  • Nagakute, Aichi, Japan
  • +2 more
Jan 25, 2022

Intradialytic Hypotension Trial (Icatibant, Placebo)

Not yet recruiting
  • Intradialytic Hypotension
  • Icatibant
  • Placebo
  • (no location specified)
Apr 17, 2023

COVID-19 Pneumonia Trial in L'Hospitalet De Llobregat (Firazyr, SoC)

Completed
  • COVID-19 Pneumonia
  • L'Hospitalet De Llobregat, Catalonia, Spain
    Hospital Universitari de Bellvitge
Aug 2, 2022

Hereditary Angioedema Trial in Milano (Icatibant, Tranexamic Acid, Oral Placebo)

Completed
Has Results
  • Hereditary Angioedema
  • Icatibant
  • +3 more
  • Milano, Italy
    Università degli Studi di Milano, Dipartimento di Medicina Inter
May 24, 2021

Hereditary Angioedema (HAE) Trial in Glendale (Icatibant (30 mg))

Completed
Has Results
  • Hereditary Angioedema (HAE)
  • Icatibant (30 mg)
  • Glendale, California
    PAREXEL
May 13, 2021

Hereditary Angioedema (HAE) Trial in Japan (Icatibant)

Completed
Has Results
  • Hereditary Angioedema (HAE)
  • Icatibant
  • Fukushima, Japan
  • +7 more
May 13, 2021

Covid19 Trial in Le Chesnay (C1 Inhibitor Human, Icatibant Injection, Placebo)

Completed
  • Covid19
  • C1 Inhibitor Human
  • +2 more
  • Le Chesnay, France
    Hôpital Privé de Parly II
Aug 17, 2021

FIRAZYR General Drug Use-Results Survey (Japan)

Recruiting
  • Hereditary Angioedema (HAE)
  • Nagoya, Aichi, Japan
  • +17 more
Feb 23, 2022

Hereditary Angioedema Trial in Worldwide (Icatibant)

Completed
Has Results
  • Hereditary Angioedema
  • Icatibant
  • Buenos Aires, Argentina
  • +25 more
Jun 1, 2021

Hereditary Angioedema Trial in Worldwide (Icatibant, Placebo)

Completed
Has Results
  • Hereditary Angioedema
  • Icatibant
  • Placebo
  • Alabaster, Alabama
  • +63 more
Jun 3, 2021

Hemodialysis-Induced Symptom, Mitochondrial Diseases Trial in Nashville (Icatibant, Placebo)

Completed
Has Results
  • Hemodialysis-Induced Symptom
  • Mitochondrial Diseases
  • Icatibant
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Oct 28, 2019

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Hereditary Angioedema Trial in Moscow, Rostov-on-Don, Stavropol' (GNR-038, 50 ??/ kg, GNR-038, 100 ??/ kg, Berinert®, 20 ??/ kg)

    Withdrawn
    • Hereditary Angioedema
    • GNR-038, 50 МЕ/ kg
    • +4 more
    • Moscow, Russian Federation
    • +4 more
    Jan 21, 2022

    Hemodialysis Complication, Hypotension of Hemodialysis Trial in Nashville (Lanadelumab Injection [Takhzyro], Placebo)

    Recruiting
    • Hemodialysis Complication
    • Hypotension of Hemodialysis
    • Lanadelumab Injection [Takhzyro]
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Aug 4, 2022

    COVID-19 Trial in Netherlands (lanadelumab, regular care)

    Completed
    • COVID-19
    • lanadelumab
    • regular care
    • Amsterdam, Netherlands
    • +3 more
    Jul 11, 2021

    Hereditary Angioedema (HAE) Trial in Worldwide (BCX7353, Placebo)

    Completed
    Has Results
    • Hereditary Angioedema (HAE)
    • Graz, Austria
    • +23 more
    Mar 8, 2021

    Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III Trial in Nashville (Valsartan 80 mg bid,

    Withdrawn
    • Heart Failure NYHA Class I
    • +2 more
    • Valsartan 80 mg bid
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 9, 2018

    Hereditary Angioedema Trial in United States (Icatibant)

    Completed
    Has Results
    • Hereditary Angioedema
    • Icatibant
    • La Jolla, California
    • +4 more
    Oct 17, 2016

    ACE Inhibitor-associated Angioedema Trial in San Diego, Nashville (icatibant, Placebo)

    Terminated
    Has Results
    • ACE Inhibitor-associated Angioedema
    • icatibant
    • Placebo
    • San Diego, California
    • +1 more
    Dec 22, 2016

    Determination of Specific Biomarkers of Angioneurotic Crisis

    Completed
    • Angioedema
      • Grenoble, France
        Grenoble university hospital
      Sep 27, 2017

      Angioneurotic Edema Trial in Nashville (HOE-140, Placebo)

      Terminated
      • Angioneurotic Edema
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Dec 16, 2015

      Availability of Treatments for ACE-I and ARB-induced Angioedema

      Completed
      • ACE-I and ARB-induced Angioedema.
        • Lyon, France
          Hospices Civils de Lyon, Département d'Anesthésie-Réanimation, H
        Jul 7, 2016